Insight Molecular Diagnostics
Common Stock · USD · NASDAQ
Price
$6.48
Cap
$34.37B
Earnings
—
30d Trend
+53.0%
138% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 48×Macro 0.99 (−1%)=48
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Short-term opportunity — technical setup
BRAIN47'S ASSESSMENT
I rate Insight Molecular Diagnostics at 48/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is technical at 72/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+70.5%
3 MONTHS
+8.7%
12 MONTHS
+100.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Short-term opportunity — technical setup. Technical (72) and Momentum (54) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 138%. I classify this as a speculative position — elevated volatility at 138% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.